Close

Brooklyn ImmunoTherapeutics (BTX) Announces Howard J. Federoff, MD, PhD Appointed Chief Executive Officer

Go back to Brooklyn ImmunoTherapeutics (BTX) Announces Howard J. Federoff, MD, PhD Appointed Chief Executive Officer
BIOTIME, Inc. (NASDAQ: BTX) Delayed: 0.21 --0 (-0%)
Previous Close $0.21    52 Week High $4.51 
Open $0.21    52 Week Low $2.02 
Day High $0.21    P/E N/A 
Day Low $0.21    EPS $-0.58 
Volume 2,808,386